Hosts:
Thierry Alcindor, MD
Dana-Farber Cancer Institute, Harvard Medical School, Boston

Inga-Marie Schaefer, MD
Brigham and Women’s Hospital & Harvard Medical School, Boston

Ian Judson, MD
The Institute of Cancer Research: Royal Cancer Hospital, London

In this episode, we learn from Ian Judson, Emeritus Professor at the Institute for Cancer Research in London, what led to his remarkable career in sarcoma oncology and the work he has been leading in the British Sarcoma Group and the EORTC. We discuss lessons learned from groundbreaking clinical trials in the GIST/sarcoma field, and hear about what Ian views as the most compelling opportunities in the sarcoma field right now. Take a listen!

Hosts:
Dario Callegaro, MD
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Nadia Hindi, MD
Fundación Jimenez Diaz University Hospital, Madrid, Spain

Sylvie Bonvalot, MD, PhD
Institut Curie Hospital, Paris

Hosts:
Sebastian Bauer, MD
West German Cancer Center, University Hospital Essen
Maureen O’Sullivan, MD
University of Dublin, Trinity College & Children’s Health Ireland

Christopher David Marsden Fletcher, MD, FRCPath
Women's Hospital and Harvard Medical School in Boston, MA

In this podcast, the iconic Professor Chris Fletcher, sadly since deceased, gives a candid account of the career path he followed to become THE internationally acclaimed sarcoma pathologist of his generation.

Hosts:
Maureen O’Sullivan, MD
University of Dublin, Trinity College & Children’s Health Ireland

Inga-Marie Schaefer, MD
Brigham and Women’s Hospital & Harvard Medical School, Boston
Featuring:

David Thomas, FRACP, PhD
University of New South Wales & Garvan Institute of Medical Research, Sydney

Dr. Thomas is Head of the Genomic Cancer Medicine Lab at Garvan Institute of Medical Research and the inaugural Director of the University of New South Wales Centre for Molecular Oncology. As a clinician-scientist, he applies genomic technologies to the understanding and management of cancer and has made groundbreaking contributions to the understanding and management of cancer, including the major inherited cancer predisposition syndromes. Dr. Thomas founded the Australasian Sarcoma Study Group, established the Australian Genomic Cancer Medicine Centre (Omico), and leads the International Sarcoma Kindred Study. In 2018, he was President of CTOS and he has been a member of CTOS for 18 years.

In this interview, Dr. Thomas will share his perspective on past, current, and emerging challenges and opportunities in the field of precision sarcoma oncology, reflect on his career path as a physician- scientist, and discuss the importance of international collaborative efforts to impact patient care.